- Premium quality compounder with a wide competitive moat.
- Reverse DCF implies ~20% perpetual growth required at current $450 price.
- Intrinsic valuation models anchor at $254.67, signaling a massive premium.
- Sell recommendation driven by extreme valuation disconnect, not business quality.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.